← Evidence map

ReviewCurrent neurology and neuroscience reports2016

Alemtuzumab for Multiple Sclerosis.

Mark D Willis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27485945